nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfanilamide—CYP2E1—Parkinson's disease	0.538	0.577	CbGaD
Sulfanilamide—CYP2D6—Parkinson's disease	0.395	0.423	CbGaD
Sulfanilamide—Sulfadiazine—CYP2E1—Parkinson's disease	0.000608	0.317	CrCbGaD
Sulfanilamide—CA7—midbrain—Parkinson's disease	0.000582	0.0592	CbGeAlD
Sulfanilamide—CA12—forebrain—Parkinson's disease	0.000573	0.0583	CbGeAlD
Sulfanilamide—CA2—hindbrain—Parkinson's disease	0.000532	0.0541	CbGeAlD
Sulfanilamide—CA6—head—Parkinson's disease	0.000489	0.0498	CbGeAlD
Sulfanilamide—CA7—cerebellum—Parkinson's disease	0.00045	0.0458	CbGeAlD
Sulfanilamide—Sulfaphenazole—CYP2D6—Parkinson's disease	0.000408	0.213	CrCbGaD
Sulfanilamide—CA9—cerebellum—Parkinson's disease	0.000396	0.0402	CbGeAlD
Sulfanilamide—Dapsone—CYP2E1—Parkinson's disease	0.000368	0.192	CrCbGaD
Sulfanilamide—CA7—brain—Parkinson's disease	0.000366	0.0372	CbGeAlD
Sulfanilamide—CYP2D6—hindbrain—Parkinson's disease	0.000338	0.0343	CbGeAlD
Sulfanilamide—CA2—embryo—Parkinson's disease	0.000333	0.0338	CbGeAlD
Sulfanilamide—CA12—head—Parkinson's disease	0.000328	0.0334	CbGeAlD
Sulfanilamide—CA12—nervous system—Parkinson's disease	0.000311	0.0316	CbGeAlD
Sulfanilamide—CA2—brainstem—Parkinson's disease	0.000305	0.031	CbGeAlD
Sulfanilamide—CA12—central nervous system—Parkinson's disease	0.000299	0.0305	CbGeAlD
Sulfanilamide—CA2—forebrain—Parkinson's disease	0.000294	0.0299	CbGeAlD
Sulfanilamide—Benzocaine—ABCB1—Parkinson's disease	0.00029	0.151	CrCbGaD
Sulfanilamide—CA2—cardiovascular system—Parkinson's disease	0.000249	0.0253	CbGeAlD
Sulfanilamide—Aminohippurate—ABCB1—Parkinson's disease	0.000243	0.127	CrCbGaD
Sulfanilamide—CA12—brain—Parkinson's disease	0.000238	0.0242	CbGeAlD
Sulfanilamide—CA2—medulla oblongata—Parkinson's disease	0.000212	0.0216	CbGeAlD
Sulfanilamide—CYP2C9—cardiovascular system—Parkinson's disease	0.00021	0.0214	CbGeAlD
Sulfanilamide—CYP2E1—cardiovascular system—Parkinson's disease	0.000199	0.0203	CbGeAlD
Sulfanilamide—CA2—midbrain—Parkinson's disease	0.000194	0.0198	CbGeAlD
Sulfanilamide—CYP2D6—brainstem—Parkinson's disease	0.000193	0.0197	CbGeAlD
Sulfanilamide—CA2—spinal cord—Parkinson's disease	0.000189	0.0193	CbGeAlD
Sulfanilamide—CYP2D6—forebrain—Parkinson's disease	0.000187	0.019	CbGeAlD
Sulfanilamide—CYP2E1—medulla oblongata—Parkinson's disease	0.00017	0.0173	CbGeAlD
Sulfanilamide—CA2—head—Parkinson's disease	0.000168	0.0171	CbGeAlD
Sulfanilamide—CA2—nervous system—Parkinson's disease	0.00016	0.0162	CbGeAlD
Sulfanilamide—CA2—central nervous system—Parkinson's disease	0.000154	0.0156	CbGeAlD
Sulfanilamide—CYP2E1—spinal cord—Parkinson's disease	0.000152	0.0155	CbGeAlD
Sulfanilamide—CA2—cerebellum—Parkinson's disease	0.00015	0.0153	CbGeAlD
Sulfanilamide—CYP2E1—head—Parkinson's disease	0.000135	0.0137	CbGeAlD
Sulfanilamide—CYP2E1—nervous system—Parkinson's disease	0.000128	0.013	CbGeAlD
Sulfanilamide—CYP2E1—central nervous system—Parkinson's disease	0.000123	0.0125	CbGeAlD
Sulfanilamide—CA2—brain—Parkinson's disease	0.000122	0.0124	CbGeAlD
Sulfanilamide—CYP2E1—cerebellum—Parkinson's disease	0.00012	0.0123	CbGeAlD
Sulfanilamide—CYP2D6—head—Parkinson's disease	0.000107	0.0109	CbGeAlD
Sulfanilamide—CYP3A4—nervous system—Parkinson's disease	0.000103	0.0105	CbGeAlD
Sulfanilamide—CYP2D6—nervous system—Parkinson's disease	0.000101	0.0103	CbGeAlD
Sulfanilamide—CYP3A4—central nervous system—Parkinson's disease	9.92e-05	0.0101	CbGeAlD
Sulfanilamide—CYP2E1—brain—Parkinson's disease	9.78e-05	0.00995	CbGeAlD
Sulfanilamide—CYP2D6—central nervous system—Parkinson's disease	9.76e-05	0.00993	CbGeAlD
Sulfanilamide—CYP2D6—cerebellum—Parkinson's disease	9.54e-05	0.0097	CbGeAlD
Sulfanilamide—CYP2D6—brain—Parkinson's disease	7.75e-05	0.00788	CbGeAlD
Sulfanilamide—CA6—Metabolism—GSTP1—Parkinson's disease	6.94e-05	0.00124	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—MAOA—Parkinson's disease	6.92e-05	0.00123	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.9e-05	0.00123	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—MAOB—Parkinson's disease	6.9e-05	0.00123	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—HMOX1—Parkinson's disease	6.84e-05	0.00122	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—CYCS—Parkinson's disease	6.81e-05	0.00121	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	6.79e-05	0.00121	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—ABCB1—Parkinson's disease	6.57e-05	0.00117	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—COMT—Parkinson's disease	6.51e-05	0.00116	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—GSTP1—Parkinson's disease	6.48e-05	0.00115	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—MAOA—Parkinson's disease	6.46e-05	0.00115	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	6.4e-05	0.00114	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—HMOX1—Parkinson's disease	6.39e-05	0.00114	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—GSTM1—Parkinson's disease	6.38e-05	0.00114	CbGpPWpGaD
Sulfanilamide—CYP2C19—Biological oxidations—COMT—Parkinson's disease	6.36e-05	0.00113	CbGpPWpGaD
Sulfanilamide—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	6.33e-05	0.00113	CbGpPWpGaD
Sulfanilamide—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	6.31e-05	0.00113	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	6.27e-05	0.00112	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	6.24e-05	0.00111	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—ABCB1—Parkinson's disease	6.13e-05	0.00109	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—GPX1—Parkinson's disease	6.1e-05	0.00109	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CYP2D6—Parkinson's disease	6.08e-05	0.00108	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—COMT—Parkinson's disease	6.03e-05	0.00107	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—GSTP1—Parkinson's disease	6e-05	0.00107	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—MAOA—Parkinson's disease	5.99e-05	0.00107	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CTGF—Parkinson's disease	5.97e-05	0.00106	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—GSTM1—Parkinson's disease	5.95e-05	0.00106	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—HMOX1—Parkinson's disease	5.92e-05	0.00105	CbGpPWpGaD
Sulfanilamide—CYP2D6—Biological oxidations—COMT—Parkinson's disease	5.85e-05	0.00104	CbGpPWpGaD
Sulfanilamide—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	5.82e-05	0.00104	CbGpPWpGaD
Sulfanilamide—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	5.82e-05	0.00104	CbGpPWpGaD
Sulfanilamide—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	5.81e-05	0.00103	CbGpPWpGaD
Sulfanilamide—CYP2C9—Biological oxidations—COMT—Parkinson's disease	5.8e-05	0.00103	CbGpPWpGaD
Sulfanilamide—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	5.77e-05	0.00103	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	5.77e-05	0.00103	CbGpPWpGaD
Sulfanilamide—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	5.76e-05	0.00103	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	5.74e-05	0.00102	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	5.74e-05	0.00102	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	5.72e-05	0.00102	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—GPX1—Parkinson's disease	5.7e-05	0.00102	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	5.69e-05	0.00101	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—ABCB1—Parkinson's disease	5.68e-05	0.00101	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—MTHFR—Parkinson's disease	5.63e-05	0.001	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CYP2E1—Parkinson's disease	5.56e-05	0.000991	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—GSTM1—Parkinson's disease	5.51e-05	0.000982	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—NQO1—Parkinson's disease	5.5e-05	0.00098	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—TH—Parkinson's disease	5.42e-05	0.000966	CbGpPWpGaD
Sulfanilamide—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	5.35e-05	0.000953	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ND3—Parkinson's disease	5.35e-05	0.000952	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—MCCC1—Parkinson's disease	5.35e-05	0.000952	CbGpPWpGaD
Sulfanilamide—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	5.3e-05	0.000945	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—GPX1—Parkinson's disease	5.28e-05	0.000941	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	5.28e-05	0.00094	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—MTHFR—Parkinson's disease	5.26e-05	0.000937	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—APOE—Parkinson's disease	5.25e-05	0.000935	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	5.23e-05	0.000932	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CYCS—Parkinson's disease	5.2e-05	0.000927	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CYP2D6—Parkinson's disease	5.13e-05	0.000913	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	5.05e-05	0.000899	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CTGF—Parkinson's disease	5.03e-05	0.000897	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—OMD—Parkinson's disease	5.03e-05	0.000895	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—TALDO1—Parkinson's disease	5.03e-05	0.000895	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.98e-05	0.000887	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—APOE—Parkinson's disease	4.9e-05	0.000873	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—MTHFR—Parkinson's disease	4.87e-05	0.000868	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	4.76e-05	0.000849	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CYP2E1—Parkinson's disease	4.69e-05	0.000835	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—NQO1—Parkinson's disease	4.64e-05	0.000826	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	4.61e-05	0.000822	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—COMT—Parkinson's disease	4.61e-05	0.000821	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—GSTP1—Parkinson's disease	4.59e-05	0.000817	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—MAOA—Parkinson's disease	4.58e-05	0.000815	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—TH—Parkinson's disease	4.57e-05	0.000814	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.55e-05	0.000811	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GCH1—Parkinson's disease	4.54e-05	0.00081	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—APOE—Parkinson's disease	4.54e-05	0.000808	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—IL6—Parkinson's disease	4.53e-05	0.000807	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—HMOX1—Parkinson's disease	4.52e-05	0.000806	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—INS—Parkinson's disease	4.48e-05	0.000798	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CYCS—Parkinson's disease	4.39e-05	0.000782	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.38e-05	0.00078	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—ABCB1—Parkinson's disease	4.34e-05	0.000774	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—GSTM1—Parkinson's disease	4.22e-05	0.000751	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—INS—Parkinson's disease	4.18e-05	0.000745	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ND3—Parkinson's disease	4.12e-05	0.000735	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—MCCC1—Parkinson's disease	4.12e-05	0.000735	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—FBP1—Parkinson's disease	4.05e-05	0.000722	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—DBH—Parkinson's disease	4.05e-05	0.000722	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GBA—Parkinson's disease	4.05e-05	0.000722	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—GPX1—Parkinson's disease	4.04e-05	0.000719	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.99e-05	0.000712	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—COMT—Parkinson's disease	3.88e-05	0.000692	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—OMD—Parkinson's disease	3.88e-05	0.000691	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—TALDO1—Parkinson's disease	3.88e-05	0.000691	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—INS—Parkinson's disease	3.88e-05	0.000691	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—GSTP1—Parkinson's disease	3.87e-05	0.000689	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—MAOA—Parkinson's disease	3.86e-05	0.000687	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.82e-05	0.000681	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—HMOX1—Parkinson's disease	3.81e-05	0.000679	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.81e-05	0.000678	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.8e-05	0.000677	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ND3—Parkinson's disease	3.79e-05	0.000676	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.79e-05	0.000676	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.77e-05	0.000672	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—MCCC1—Parkinson's disease	3.76e-05	0.00067	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ND3—Parkinson's disease	3.76e-05	0.00067	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.75e-05	0.000669	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—MTHFR—Parkinson's disease	3.73e-05	0.000664	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	3.68e-05	0.000655	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—ABCB1—Parkinson's disease	3.66e-05	0.000652	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.57e-05	0.000635	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—OMD—Parkinson's disease	3.57e-05	0.000635	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—GSTM1—Parkinson's disease	3.55e-05	0.000633	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—TALDO1—Parkinson's disease	3.54e-05	0.00063	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—OMD—Parkinson's disease	3.54e-05	0.00063	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GCH1—Parkinson's disease	3.51e-05	0.000625	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.5e-05	0.000623	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—APOE—Parkinson's disease	3.47e-05	0.000618	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.45e-05	0.000615	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—GPX1—Parkinson's disease	3.4e-05	0.000606	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.38e-05	0.000602	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.35e-05	0.000597	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.23e-05	0.000575	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.2e-05	0.00057	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.16e-05	0.000564	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—MTHFR—Parkinson's disease	3.14e-05	0.00056	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—DBH—Parkinson's disease	3.13e-05	0.000557	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—FBP1—Parkinson's disease	3.13e-05	0.000557	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GBA—Parkinson's disease	3.13e-05	0.000557	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—DDC—Parkinson's disease	2.97e-05	0.00053	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—INS—Parkinson's disease	2.96e-05	0.000528	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—APOE—Parkinson's disease	2.92e-05	0.000521	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.88e-05	0.000514	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GBA—Parkinson's disease	2.87e-05	0.000512	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—DBH—Parkinson's disease	2.87e-05	0.000512	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.87e-05	0.000512	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GBA—Parkinson's disease	2.85e-05	0.000508	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—DBH—Parkinson's disease	2.85e-05	0.000508	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—FBP1—Parkinson's disease	2.85e-05	0.000508	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.81e-05	0.0005	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	2.53e-05	0.00045	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—MAOB—Parkinson's disease	2.5e-05	0.000446	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—INS—Parkinson's disease	2.5e-05	0.000445	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ND3—Parkinson's disease	2.48e-05	0.000442	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.48e-05	0.000442	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.33e-05	0.000415	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—OMD—Parkinson's disease	2.33e-05	0.000415	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—DDC—Parkinson's disease	2.29e-05	0.000409	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.21e-05	0.000394	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.17e-05	0.000386	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.14e-05	0.000381	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—DDC—Parkinson's disease	2.11e-05	0.000376	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.11e-05	0.000376	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—DDC—Parkinson's disease	2.09e-05	0.000373	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.99e-05	0.000355	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.98e-05	0.000352	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.95e-05	0.000348	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.95e-05	0.000348	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.93e-05	0.000344	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.88e-05	0.000335	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—DBH—Parkinson's disease	1.88e-05	0.000335	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GBA—Parkinson's disease	1.88e-05	0.000335	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.86e-05	0.000331	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.84e-05	0.000327	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.83e-05	0.000325	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.79e-05	0.00032	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.78e-05	0.000317	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.78e-05	0.000316	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.76e-05	0.000314	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.68e-05	0.0003	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.68e-05	0.000299	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—TH—Parkinson's disease	1.66e-05	0.000295	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.59e-05	0.000284	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.43e-05	0.000256	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—COMT—Parkinson's disease	1.41e-05	0.000251	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.41e-05	0.000251	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.4e-05	0.00025	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.4e-05	0.000249	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.38e-05	0.000247	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—DDC—Parkinson's disease	1.38e-05	0.000246	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.33e-05	0.000237	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.31e-05	0.000234	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.31e-05	0.000233	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.3e-05	0.000232	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.3e-05	0.000231	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.3e-05	0.000231	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.29e-05	0.00023	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.28e-05	0.000229	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—TH—Parkinson's disease	1.28e-05	0.000228	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.23e-05	0.00022	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.23e-05	0.000219	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.21e-05	0.000215	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.2e-05	0.000213	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.19e-05	0.000213	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.18e-05	0.000211	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—TH—Parkinson's disease	1.18e-05	0.00021	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.17e-05	0.000209	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—TH—Parkinson's disease	1.17e-05	0.000208	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.16e-05	0.000207	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.14e-05	0.000203	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.13e-05	0.000201	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.12e-05	0.0002	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—COMT—Parkinson's disease	1.09e-05	0.000194	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.08e-05	0.000193	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.08e-05	0.000192	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.07e-05	0.00019	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—APOE—Parkinson's disease	1.06e-05	0.000189	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.02e-05	0.000183	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—COMT—Parkinson's disease	1e-05	0.000178	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	9.96e-06	0.000177	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GSTM1—Parkinson's disease	9.95e-06	0.000177	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—MAOA—Parkinson's disease	9.93e-06	0.000177	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—COMT—Parkinson's disease	9.92e-06	0.000177	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GSTP1—Parkinson's disease	9.87e-06	0.000176	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—MAOA—Parkinson's disease	9.85e-06	0.000175	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	9.82e-06	0.000175	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—HMOX1—Parkinson's disease	9.73e-06	0.000173	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GPX1—Parkinson's disease	9.53e-06	0.00017	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	9.42e-06	0.000168	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ABCB1—Parkinson's disease	9.34e-06	0.000166	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	9.15e-06	0.000163	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GSTM1—Parkinson's disease	9.07e-06	0.000162	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—INS—Parkinson's disease	9.06e-06	0.000161	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—MTHFR—Parkinson's disease	8.79e-06	0.000157	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GPX1—Parkinson's disease	8.76e-06	0.000156	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GPX1—Parkinson's disease	8.69e-06	0.000155	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	8.63e-06	0.000154	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CTGF—Parkinson's disease	8.47e-06	0.000151	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—APOE—Parkinson's disease	8.18e-06	0.000146	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	8.09e-06	0.000144	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—MTHFR—Parkinson's disease	8.02e-06	0.000143	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	7.89e-06	0.000141	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NQO1—Parkinson's disease	7.8e-06	0.000139	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—TH—Parkinson's disease	7.69e-06	0.000137	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—APOE—Parkinson's disease	7.53e-06	0.000134	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—APOE—Parkinson's disease	7.46e-06	0.000133	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CYCS—Parkinson's disease	7.38e-06	0.000132	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—INS—Parkinson's disease	6.99e-06	0.000125	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—COMT—Parkinson's disease	6.54e-06	0.000117	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.51e-06	0.000116	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.49e-06	0.000116	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—INS—Parkinson's disease	6.43e-06	0.000115	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.42e-06	0.000114	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—INS—Parkinson's disease	6.37e-06	0.000114	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.16e-06	0.00011	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	5.98e-06	0.000107	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GPX1—Parkinson's disease	5.73e-06	0.000102	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.29e-06	9.42e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—APOE—Parkinson's disease	4.92e-06	8.77e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—INS—Parkinson's disease	4.2e-06	7.49e-05	CbGpPWpGaD
